Hepatology

The study’s findings demonstrate that hypovolaemic phlebotomy effectively reduces the need for red blood cell transfusions.

Obesity and diabetes mellitus are widely acknowledged risk factors for the development of steatotic liver diseases, contributing to liver cirrhosis and HCC.

Cirrhosis-associated immune dysfunction heightens infection susceptibility through low-grade systemic inflammation and gut-liver axis alterations.

This study demonstrates that combining vibration-controlled transient elastography with retina scanning offers a practical strategy for identifying individuals with potential liver fibrosis.

These findings suggest that dihydroxyacetone phosphate, along with alanine transaminase, could serve as a valuable non-invasive biomarker for liver fibrosis.

These disruptions may play a pathophysiological role in metabolic dysfunction-associated steatotic liver disease development.

Recent research highlights the discovery of 17 novel loci associated with liver triglycerides and 9 linked to liver inflammation.

Recent studies have highlighted the potential of sodium-glucose cotransporter 2 inhibitors, especially ertugliflozin, in improving outcomes for patients with NAFLD and T2DM.